Qing Li
Radiation Oncology Resident, University Hospitals
Qing is a radiation oncology resident at Case Western Reserve University / University Hospitals Cleveland Medical Center. She completed her medical training at Qingdao University before earning her PhD in molecular and cellular biology, where she studied regenerating proteins involved in beta cell regeneration and pancreatic carcinogenesis. Her early work led to the development of biomarkers for pancreatic cancer detection and novel metabolic targets for diabetes and fatty liver disease.
She went on to complete postdoctoral research at Memorial Sloan-Kettering Cancer Center, where she investigated mechanisms of resistance to endocrine and HER2-targeted therapies in breast cancer. Her research identified novel resistance mechanisms and therapeutic targets, culminating in the development of dual CDK4/6 PROTAC degraders now under patent. As a resident, she has launched a translational research program focused on radiation-induced modulation of HER2 expression to enhance antibody-drug conjugate (ADC) efficacy in HER2-low breast cancer.
Qing is joining the Miller Lab as a resident researcher to further explore the spatial and genomic landscape of breast cancer brain metastases and radiation-induced targetability.
Outside the hospital, she enjoys spending time with her family, dancing, and playing the GuZheng- a traditional Chinese string instrument.